Ocugen, Inc. (OCGN)
1.77
-0.02
(-1.12%)
USD |
NASDAQ |
Apr 02, 10:39
Ocugen Research and Development Expense (TTM) : 37.87M for Dec. 31, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| REGENXBIO, Inc. | 212.68M |
| Krystal Biotech, Inc. | 55.08M |
| Phathom Pharmaceuticals, Inc. | 32.78M |
| MannKind Corp. | 66.35M |
| Altimmune, Inc. | 66.32M |